Systemic activation and tissue infiltration of CD8 + CX3CR1 + T cells in non-small cell lung cancer treated with neoadjuvant immune checkpoint blockade
机构:[1]Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.四川大学华西医院[2]Center of Gerontology and Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China四川大学华西医院[3]Institute of Thoracic Oncology, Frontiers Science Center for Disease-related Molecular Networks, West China Hospital, Sichuan University, Chengdu, Sichuan, China.四川大学华西医院[4]Departments of Obstetrics and Gynecology and Pediatrics, West China Second University Hospital, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Development and Related Diseases of Women and Children Key Laboratory of Sichuan Province, Sichuan University, Chengdu, Sichuan, China.[5]Department of Pulmonary and Critical Care Medicine, West China Hospital, State Key Laboratory of Respiratory Health and Multimorbidity, Sichuan University, Chengdu, Sichuan, China.四川大学华西医院[6]Department of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan, China四川大学华西医院[7]Center for Infectious Disease and Vaccine Research, West China Hospital, Sichuan University, Chengdu, Sichuan, China四川大学华西医院[8]Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.四川大学华西医院[9]Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China四川大学华西医院[10]Cicada Bio., Shanghai, China,Dolphin Biosciences Co. Ltd, Hangzhou, Zhejiang, China
This project was supported by the National Natural Science Foundation of China,
China (81972911), Disciplinary Excellence Development 1·3·5 Project, West China
Hospital, Sichuan University, China (ZYJC21052), Natural Science Foundation of
Sichuan Province, China (2022NSFSC0689), Post-Doctor Research Project, West China
Hospital, Sichuan University, China (2021HXBH070).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类|2 区医学
小类|2 区肿瘤学
最新[2025]版:
大类|2 区医学
小类|2 区肿瘤学
第一作者:
第一作者机构:[1]Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.[2]Center of Gerontology and Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China
共同第一作者:
通讯作者:
通讯机构:[1]Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.[8]Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.[9]Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China[10]Cicada Bio., Shanghai, China,Dolphin Biosciences Co. Ltd, Hangzhou, Zhejiang, China
推荐引用方式(GB/T 7714):
Sisi Dai,Yongcheng Liu,Tingting Guo,et al.Systemic activation and tissue infiltration of CD8 + CX3CR1 + T cells in non-small cell lung cancer treated with neoadjuvant immune checkpoint blockade[J].British Journal Of Cancer.2025,doi:10.1038/s41416-025-03160-9.
APA:
Sisi Dai,Yongcheng Liu,Tingting Guo,Hong Luo,Guanglei Yang...&Xuyu Cai.(2025).Systemic activation and tissue infiltration of CD8 + CX3CR1 + T cells in non-small cell lung cancer treated with neoadjuvant immune checkpoint blockade.British Journal Of Cancer,,
MLA:
Sisi Dai,et al."Systemic activation and tissue infiltration of CD8 + CX3CR1 + T cells in non-small cell lung cancer treated with neoadjuvant immune checkpoint blockade".British Journal Of Cancer .(2025)